C

UPERTINO, Calif. — The Japanese drug maker Otsuka markets chemotherapies for leukemia, antidepressants for schizophrenia, and a pill that can alert your doctor when you swallow it. It also grows grapes and sells cabernet sauvignon.

Here in the upper reaches of the sun-kissed mountains just south of Stanford, you can find perhaps the oddest outpost of a powerful pharma company’s global operations: an upscale winery where weathered wooden signs warn tipsy tourists to “beware of rattlesnakes” just steps from the tasting room.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy